What to Do When a Pharma Campaign Underdelivers
A constraint ladder for diagnosing pharma programmatic underdelivery, checking setup, approvals, audience, inventory, and bids before loosening safeguards.
The short answer
Underdelivery means a campaign is spending less than planned. The quick fix is to raise bids or loosen targeting. Both can work, and both can damage quality or compliance. In pharma, where audiences are narrow and safeguards matter, the better approach is to find the actual constraint first. A constraint ladder orders the checks from most common and least risky to least common and most consequential.
The constraint ladder
Step 1: Setup errors
- Are flight dates, budgets, and pacing settings correct?
- Are all line items active?
- Are creatives approved in the platform and by the exchange?
Setup errors are the most common cause and the easiest to fix.
Step 2: Creative approval and eligibility
- Have exchanges or publishers rejected any creatives?
- Do creative sizes and formats match available inventory?
- Are healthcare policies restricting some inventory? Some platforms have specific healthcare advertising policies.
Step 3: Audience size
- How large is the matched audience in the platform?
- Has the segment shrunk since planning?
- Are exclusions removing more than expected?
Small audiences limit delivery no matter how high the bid. See target-list reach.
Step 4: Inventory availability
- Are deals delivering expected volume?
- Are allowlists too narrow?
- Is the inventory type available at the planned scale?
Step 5: Frequency caps
- Is much of the audience already at the cap?
- If so, the constraint is audience size, not bids.
Step 6: Bids and floors
- Are bids below floor prices for key inventory?
- Are win rates low?
Only after these checks should bids change.
Changes to avoid
| Tempting fix | Risk |
|---|---|
| Removing exclusions | Compliance and brand safety exposure |
| Loosening audience to broad segments | Lower on-target delivery, weaker results |
| Removing allowlists | Low-quality inventory |
| Raising frequency caps sharply | Waste and fatigue |
If one of these is necessary, get approval and document it.
Sometimes underdelivery is the right outcome
If the audience is small and the inventory is limited, the plan may simply have been too large. Reallocating budget to another channel or partner may be better than forcing delivery. See scenario planning.
Watch for side effects
After fixing underdelivery, check the inventory mix and quality metrics. A sudden jump in delivery can mean the campaign found cheaper, lower-quality supply.
Practical takeaway
Work down the ladder in order and log what you find at each step. Change bids only after steps one through five are clear, and never remove safeguards without documented approval.
Sources
External guidance and platform documentation change. Links were current at publication; check them again before relying on them for a decision.
Editorial note. Analysis and frameworks are the author's own and do not represent Acxiom or any current or former employer, client, or named platform. Examples labeled hypothetical or illustrative are not results from real campaigns. Nothing here is legal, regulatory, or medical advice.
New pharma programmatic breakdowns, occasionally
One email when I publish something worth reading. Benchmarks, measurement teardowns, and case studies with the caveats attached. No cadence promises, no reselling your address.
Unsubscribe any time. See the privacy policy.
Working through this decision on a real plan?
I work on health and pharma data, identity, and activation, after five years running HCP and DTC programmatic agency-side. Happy to talk through how this applies to your situation.